促进药师转诊以启动循证他汀治疗:两项整群随机临床试验
两项实用整群随机试验在社区医疗系统12个初级保健诊所开展,评估两种转诊药师管理血脂的干预对他汀处方的影响。试验1的访视时中断性电子提醒未显著增加处方(15.6% vs 11.6%,差值3.9个百分点,95%CI -0.4~8.3);试验2的异步半自动药师转诊显著增加处方(31.6% vs 15.2%,差值16.4个百分点,95%CI 12.7~20.1)。
要点
- 访视时中断性电子提醒未显著提高他汀处方率。
- 异步半自动药师转诊使处方率提高16.4个百分点。
- 异步转诊策略可能可扩展且有效,用于高危患者他汀启动。
核心结论
- 访视时中断性提醒与他汀处方显著增加无关,而异步半自动药师转诊策略与他汀处方大幅增加相关。
研究设计与样本
- 两项实用整群随机临床试验在社区医疗系统12个初级保健诊所开展,共纳入1412例(试验1)和1950例(试验2)有中高强度他汀适应证但未处方或剂量不足的患者。
- 试验1为延迟干预设计,在单个诊所按临床医生随机;试验2为平行组试验,在11个诊所按诊所随机。
主要发现
- 试验1中中断性电子提醒组他汀处方率15.6%,常规护理组11.6%,未调整绝对差3.9个百分点(95%CI -0.4~8.3)。
- 试验2中异步半自动药师转诊组他汀处方率31.6%,常规护理组15.2%,未调整绝对差16.4个百分点(95%CI 12.7~20.1)。
关键数值与推荐
- 纳入标准:有高强度或中等强度他汀适应证,且未处方他汀或处方剂量不适当偏低。
- 患者平均(SD)年龄65.6(9.9)岁,女性1485例(44.2%),基线10年主要心血管事件平均(SD)风险17.9%(9.4)。
临床怎么用
- 对于有他汀适应证但未治疗或剂量不足的高危患者,可考虑采用异步半自动转诊药师共管血脂的策略以提高他汀处方率。
- 访视时中断性电子提醒可能不足以显著改善他汀处方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite statins' benefit in preventing major adverse cardiovascular events, most patients with an indication for statin therapy are not appropriately treated. Clinicians' limited time and lack of systematic efforts to address preventive care likely contribute to gaps in statin prescribing. OBJECTIVE: To determine the effect on statin prescribing of 2 interventions to refer appropriate patients to a pharmacist for lipid management. DESIGN, SETTING, AND PARTICIPANTS: These 2 pragmatic cluster randomized clinical trials were conducted among 12 total primary care practices in a community health system. Trial 1 was a delayed-intervention design of a visit-based intervention with randomization at the clinician level in a single clinic, and trial 2 was a parallel-arm trial of an asynchronous intervention with randomization at the clinic level in 11 clinics. Patients who were assigned to a primary care clinician at a participating practice, had an indication for a high-intensity or moderate-intensity statin, and were either not prescribed a statin or prescribed an inappropriately low statin dose were eligible for inclusion. INTERVENTION: Trial 1 tested an interruptive electronic health record alert that appeared during eligible patients' visits and facilitated referral to a pharmacist, while trial 2 tested an order for pharmacist referral placed by the study team for cosignature by the primary care clinician without regard to the timing of a clinic visit. MAIN OUTCOME AND MEASURE: The primary outcome was the proportion of patients prescribed a statin. RESULTS: Overall, 1412 patients were enrolled in trial 1 and 1950 in trial 2. Across both trials, mean (SD) patient age was 65.6 (9.9) years, and 1485 patients (44.2%) were female. Mean (SD) baseline 10-year risk of major cardiovascular events was 17.9% (9.4). In trial 1, the interruptive alert was not associated with a significant increase in statin prescriptions compared with usual care (15.6% vs 11.6%; unadjusted absolute difference, 3.9 percentage points; 95% CI, -0.4 to 8.3). In trial 2, semiautomated pharmacist referrals were associated with an increase in statin prescriptions by 16 percentage points compared with usual care (31.6% vs 15.2%; unadjusted absolute difference, 16.4 percentage points; 95% CI, 12.7-20.1). CONCLUSIONS AND RELEVANCE: In these 2 cluster randomized clinical trials, visit-based interruptive alerts were not associated with a significant increase in statin prescribing compared with usual care, whereas a strategy of asynchronous semiautomated referral for pharmacist comanagement was associated with a substantial increase. This strategy of asynchronous semiautomated referrals for pharmacist involvement in lipid management could be a scalable and effective approach to increasing statin prescribing for patients at high risk. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05537064.
引用
- Fanaroff AC, Huang Q, Clark K, et al. Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation: Two Cluster Randomized Clinical Trials. JAMA Cardiol. 2025. PMID: 40136263. doi:10.1001/jamacardio.2025.0244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。